Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ringe

Showing results (151-160 of 316) with videos related to

Pageof 32
Sort By:
Rheumatology International|January 12, 2007
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)J D Ringe, P Farahmand, E Schacht, et al.
Rheumatology International|September 3, 2008
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year studyJohann D Ringe, Parvis Farahmand, Herbert Faber, et al.
The Journal of Rheumatology. Supplement|September 6, 2005
Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosisJohann D Ringe, Herbert Faber, Parvis Fahramand, et al.
Rheumatology International|September 19, 2003
Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm studyJ D Ringe, A Dorst, H Faber, et al.
Arzneimittel-Forschung|September 1, 1990
[Intranasal salmon calcitonin for the prophylaxis of bone mineral loss in steroid-treated chronic obstructive lung diseases ]W Böhning, J D Ringe, D Welzel, et al.
Arzneimittel-Forschung|September 25, 2010
Effect of a six-month therapy with alfacalcidol on muscle power and balance and the number of fallers and fallsLaurent Dukas, Erich Schacht, Martin Runge, et al.
Biophysical Journal|September 1, 1989
Charge motion in MbCO crystals after flash photolysisI E Iben, L Keszthelyi, D Ringe, et al.
Arzneimittel-Forschung|August 16, 2003
Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysisJohann D Ringe, Dirk Miethe, David Pittrow, et al.
Deutsche Medizinische Wochenschrift (1946)|July 24, 1987
[Non-tropical sprue, a frequently unrecognized cause of high-grade generalized osteopathy]H P Kruse, J D Ringe, R Tomforde-Brunckhorst
Rheumatology International|July 8, 2005
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year studyJ D Ringe, H Faber, P Farahmand, et al.
Pageof 32

Showing results (151-160 of 316) with videos related to

Sort By:
Pageof 32
Rheumatology International|January 12, 2007
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)J D Ringe, P Farahmand, E Schacht, et al.
Rheumatology International|September 3, 2008
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year studyJohann D Ringe, Parvis Farahmand, Herbert Faber, et al.
The Journal of Rheumatology. Supplement|September 6, 2005
Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosisJohann D Ringe, Herbert Faber, Parvis Fahramand, et al.
Rheumatology International|September 19, 2003
Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm studyJ D Ringe, A Dorst, H Faber, et al.
Arzneimittel-Forschung|September 1, 1990
[Intranasal salmon calcitonin for the prophylaxis of bone mineral loss in steroid-treated chronic obstructive lung diseases ]W Böhning, J D Ringe, D Welzel, et al.
Arzneimittel-Forschung|September 25, 2010
Effect of a six-month therapy with alfacalcidol on muscle power and balance and the number of fallers and fallsLaurent Dukas, Erich Schacht, Martin Runge, et al.
Biophysical Journal|September 1, 1989
Charge motion in MbCO crystals after flash photolysisI E Iben, L Keszthelyi, D Ringe, et al.
Arzneimittel-Forschung|August 16, 2003
Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysisJohann D Ringe, Dirk Miethe, David Pittrow, et al.
Deutsche Medizinische Wochenschrift (1946)|July 24, 1987
[Non-tropical sprue, a frequently unrecognized cause of high-grade generalized osteopathy]H P Kruse, J D Ringe, R Tomforde-Brunckhorst
Rheumatology International|July 8, 2005
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year studyJ D Ringe, H Faber, P Farahmand, et al.
Pageof 32